DENTSPLY SIRONA Inc. 8-K

What Happened

• DENTSPLY SIRONA Inc. filed an 8‑K reporting the results of its Annual Meeting of Stockholders held on June 2, 2026 (filed June 4, 2026). All twelve director nominees were elected and Deloitte & Touche LLP was ratified as the company’s independent auditor. Shareholders also approved, on a non‑binding basis, the company’s 2025 executive compensation and approved Amendment No. 2 to the 2024 Omnibus Incentive Plan to add 15,000,000 shares.

Key Details

• Directors elected: all 12 nominees received majority support; notable vote totals include Donald J. Zurbay — 116,568,821 For, 51,059,271 Against, 213,223 Abstain; Betsy D. Holden — 144,275,619 For, 23,407,281 Against, 158,415 Abstain.
• Auditor ratification: Deloitte & Touche LLP ratified as independent registered public accountants — 182,033,381 For, 465,064 Against, 105,792 Abstain.
• Say‑on‑Pay (non‑binding): executive compensation for 2025 approved — 158,496,058 For, 9,090,084 Against, 255,173 Abstain (14,762,922 broker non‑votes).
• 2024 Omnibus Incentive Plan Amendment No. 2 approved to increase share reserve by 15,000,000 shares — 139,933,388 For, 27,713,777 Against, 194,150 Abstain (14,762,922 broker non‑votes).

Why It Matters

• Board and auditor continuity: re‑electing the full slate of directors and ratifying Deloitte maintains leadership and audit continuity.
• Shareholder sentiment signals: although all nominees were elected, several directors received significant opposition (millions of votes Against), which investors may view as a message about governance or performance.
• Compensation and dilution: the non‑binding approval of executive pay shows majority shareholder support for 2025 compensation; the approved 15M‑share increase to the equity plan creates potential future dilution tied to grants under the 2024 Plan.

Filed and signed by CEO Daniel T. Scavilla on June 4, 2026.